Locations
San Francisco, CA, USA · Emeryville, CA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2019
Aralez Bio specializes in the production of noncanonical amino acids (ncAAs) through a unique enzymatic method that allows for efficient and sustainable synthesis. Their innovative approach not only reduces costs and lead times but also addresses supply chain uncertainties, making them a key player in the biotech and pharmaceutical industries. With a focus on high-quality, sustainable products made in the USA, Aralez Bio is positioned to support drug discovery and development, providing critical building blocks for peptide drugs and other therapeutics. Their technology has garnered positive feedback from major pharmaceutical companies, highlighting its potential to transform drug development processes.
Something looks off?